Compartir

Acceso a la atención médica Press Releases

16 de Enero de 2025

Activistas de la lucha contra el cáncer esperan que la gobernadora Hochul aborde las preocupaciones sobre los costos a lo largo del continuo del cáncer en el presupuesto ejecutivo 2025-26

La siguiente es una declaración del Director Senior de Relaciones Gubernamentales de Nueva York de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN, por sus siglas en inglés), Michael Davoli:

“Tras el discurso sobre la situación del Estado de la Gobernadora Hochul a principios de esta semana, donde en contadas ocasiones se mencionaron el acceso y los costos de la atención médica, los defensores de los pacientes tienen la esperanza de que la gobernadora priorice los bajos costos de la atención médica en su propuesta de presupuesto ejecutivo para el año fiscal 2025-26.

14 de Enero de 2025

New Report Underscores Importance of RI Proposals Aiming to Limit Out-of-pocket Costs across Cancer Continuum

As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them. 

13 de Enero de 2025

New Report Underscores Importance of VA Proposal Limiting Out-of-pocket Costs for Diagnostic Tests for Breast Cancer

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

13 de Enero de 2025

New Report Underscores Importance of PA Proposal Limiting Out-of-pocket Costs for Diagnostic Tests for Breast Cancer

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.